Investors Sell UnitedHealth Group Incorporated (UNH) on Strength (UNH)
Investors sold shares of UnitedHealth Group Incorporated (NYSE:UNH) on strength during trading on Friday. $112.01 million flowed into the stock on the tick-up and $145.98 million flowed out of the stock on the tick-down, for a money net flow of $33.97 million out of the stock. Of all companies tracked, UnitedHealth Group had the 0th highest net out-flow for the day. UnitedHealth Group traded up $0.16 for the day and closed at $198.06
UNH has been the subject of a number of research analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $208.00 price target on shares of UnitedHealth Group in a report on Friday, July 21st. ValuEngine raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Oppenheimer Holdings, Inc. reissued an “outperform” rating and issued a $205.00 price objective (up from $203.00) on shares of UnitedHealth Group in a report on Friday, July 21st. Finally, BidaskClub downgraded UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 19th. Three investment analysts have rated the stock with a hold rating and twenty-three have issued a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $203.59.
The company has a market capitalization of $191.50 billion, a PE ratio of 23.79 and a beta of 0.63. The firm has a 50 day moving average of $196.36 and a 200 day moving average of $183.56.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. During the same quarter in the previous year, the firm posted $1.96 EPS. The business’s revenue for the quarter was up 7.7% compared to the same quarter last year. On average, analysts anticipate that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 19th. Investors of record on Friday, September 8th were given a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.51%. UnitedHealth Group’s dividend payout ratio is currently 35.13%.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the completion of the transaction, the director now owns 60,834 shares in the company, valued at approximately $12,135,774.66. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Larry C. Renfro sold 50,574 shares of the business’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $198.11, for a total value of $10,019,215.14. Following the transaction, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. Insiders have sold a total of 76,174 shares of company stock valued at $14,981,909 in the last 90 days. Insiders own 0.89% of the company’s stock.
A number of hedge funds have recently made changes to their positions in UNH. Harbour Capital Advisors LLC boosted its position in UnitedHealth Group by 18,383.4% during the 2nd quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock worth $13,573,000 after acquiring an additional 2,503,090 shares during the period. Janus Henderson Group PLC boosted its position in UnitedHealth Group by 1,820.1% during the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after acquiring an additional 2,264,242 shares during the period. Vanguard Group Inc. boosted its position in UnitedHealth Group by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after acquiring an additional 1,588,516 shares during the period. Parametric Portfolio Associates LLC boosted its position in UnitedHealth Group by 77.3% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock worth $664,570,000 after acquiring an additional 1,562,661 shares during the period. Finally, Jennison Associates LLC boosted its position in UnitedHealth Group by 180.4% during the 2nd quarter. Jennison Associates LLC now owns 2,252,507 shares of the healthcare conglomerate’s stock worth $417,660,000 after acquiring an additional 1,449,130 shares during the period. Institutional investors own 86.19% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.